3.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.36
Aprire:
$3.32
Volume 24 ore:
3.38M
Relative Volume:
0.69
Capitalizzazione di mercato:
$342.78M
Reddito:
-
Utile/perdita netta:
$-258.08M
Rapporto P/E:
-1.1673
EPS:
-2.75
Flusso di cassa netto:
$-202.32M
1 W Prestazione:
-3.89%
1M Prestazione:
+15.88%
6M Prestazione:
-70.03%
1 anno Prestazione:
-87.18%
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Nome
Rocket Pharmaceuticals Inc
Settore
Industria
Telefono
646-440-9100
Indirizzo
350 FIFTH AVENUE, NEW YORK, NY
Confronta RCKT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
RCKT
Rocket Pharmaceuticals Inc
|
3.21 | 362.00M | 0 | -258.08M | -202.32M | -2.75 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-30 | Downgrade | Evercore ISI | Outperform → In-line |
2025-05-28 | Downgrade | Goldman | Neutral → Sell |
2025-05-28 | Downgrade | JP Morgan | Overweight → Neutral |
2025-05-28 | Downgrade | Jefferies | Buy → Hold |
2025-05-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
2025-05-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2025-05-27 | Downgrade | Needham | Buy → Hold |
2025-05-27 | Downgrade | TD Cowen | Buy → Hold |
2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
2024-12-30 | Iniziato | Wedbush | Outperform |
2024-12-18 | Iniziato | Jefferies | Buy |
2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
2024-04-02 | Iniziato | Goldman | Neutral |
2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
2023-02-01 | Iniziato | Morgan Stanley | Overweight |
2022-11-08 | Iniziato | Canaccord Genuity | Buy |
2022-11-01 | Iniziato | BTIG Research | Buy |
2022-07-08 | Iniziato | Raymond James | Outperform |
2021-10-20 | Ripresa | Cowen | Outperform |
2021-03-02 | Iniziato | Stifel | Buy |
2021-02-18 | Iniziato | Needham | Buy |
2020-12-16 | Iniziato | UBS | Buy |
2020-12-08 | Downgrade | Oppenheimer | Outperform → Perform |
2020-07-02 | Iniziato | JP Morgan | Overweight |
2020-06-25 | Ripresa | BofA/Merrill | Buy |
2020-06-01 | Ripresa | Oppenheimer | Outperform |
2019-11-06 | Iniziato | Chardan Capital Markets | Buy |
2019-09-26 | Iniziato | Piper Jaffray | Overweight |
2019-04-23 | Iniziato | Robert W. Baird | Outperform |
2019-03-15 | Iniziato | BofA/Merrill | Buy |
2019-02-05 | Iniziato | Oppenheimer | Outperform |
2018-09-13 | Iniziato | Ladenburg Thalmann | Buy |
2018-07-10 | Iniziato | William Blair | Outperform |
Mostra tutto
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - TradingView
Levi & Korsinsky Urges Rocket Pharmaceuticals, Inc. (RCKT) Shareholders to Act Before Lead Plaintiff Deadline August 11, 2025 - Barchart.com
Investor Alert: Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Trial Safety Concerns - TradingView
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
What analysts say about Rocket Pharmaceuticals Inc. Equity Warrant stockAccelerated investment success - PrintWeekIndia
Rocket Pharmaceuticals to cut 30% of workforce - NJBIZ
Rocket Pharma falls on delay of certain drug development programs - TradingView
Rocket Pharmaceuticals (RCKT) Restructures, Cuts Workforce by 30% - GuruFocus
Rocket Pharmaceuticals cuts headcount, realigns pipeline - Seeking Alpha
The Fragile Equilibrium: Assessing Rocket Pharmaceuticals Amid Securities Litigation and Governance Concerns - AInvest
Rocket Pharmaceuticals (RCKT) Restructures for Strategic Focus a - GuruFocus
Rocket Pharmaceuticals Announces Strategic Reorganization - TipRanks
Rocket Pharmaceuticals cuts workforce by 30% to focus on heart therapies - Investing.com Australia
Rocket Pharmaceuticals Announces Strategic Corporate Reorganizat - GuruFocus
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs - Business Wire
FDA Clinical Hold on RP-A501 Trial Triggers Rocket - GlobeNewswire
Rocket Pharmaceuticals Announces Strategic Reorganization Plan - TipRanks
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky - Barchart.com
Investor Alert: Securities Class Action Filed Against Rocket Pharmaceuticals (RCKT) - TradingView
RCKT Class Action Reminder: Robbins LLP Reminds Rocket Pharmaceuticals, Inc. Investors of the Class Action LawsuitContact us for more information - PR Newswire
RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - PR Newswire
RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - PR Newswire
Signaturefd LLC Increases Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastMarket-leading capital gains - Autocar Professional
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - StreetInsider
Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline - Barchart.com
Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop - TradingView
ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket - GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT - GlobeNewswire Inc.
FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class ActionHagens Berman - TradingView
Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
What drives Rocket Pharmaceuticals Inc. Equity Warrant stock priceTremendous growth potential - jammulinksnews.com
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join - GlobeNewswire
ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER - GlobeNewswire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Rocket Pharmaceuticals Inc (RCKT) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT)August 11, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Is Rocket Pharmaceuticals Inc. a good long term investmentAccelerated capital growth - jammulinksnews.com
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 - ACCESS Newswire
2025-07-20 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse
What analysts say about Rocket Pharmaceuticals Inc. stockRapid-fire capital growth - jammulinksnews.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
2025-07-20 | RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. InvestorsLead Plaintiff Deadline August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse
2025-07-19 | RCKT ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Rocket Pharmaceuticals, Inc.August 11, 2025 Deadline | NDAQ:RCKT | Press Release - Stockhouse
What drives Rocket Pharmaceuticals Inc. stock priceHigh-profit trading signals - Jammu Links News
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rocket - GlobeNewswire
Rocket Pharmaceuticals Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com
Is Rocket Pharmaceuticals Inc. Equity Warrant a good long term investmentUnrivaled growth potential - jammulinksnews.com
2025-07-18 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky | NDAQ:RCKT | Press Release - Stockhouse
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky Before August 11, 2025 to Join Class Action - TradingView
Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):